Case Report: Treatment of Kala-Azar by Amphotericin B Lipid Complex (ABELCET®)
PDF
Cite
Share
Request
Original Article
P: 126-128
September 2004

Case Report: Treatment of Kala-Azar by Amphotericin B Lipid Complex (ABELCET®)

Turkiye Parazitol Derg 2004;28(3):126-128
1. Tepecik Social Security Association Hospital Department of Infectious Diseases and Clinical Microbiology, Yenisehir, Izmir, Turkey
2. Tepecik Social Security Association Hospital Department of Infectious Diseases and Clinical Microbiology, Yenisehir, Izmir
3. Ege University Medical School Department of Parasitology, Bornova, İzmir, Turkey
4. Celal Bayar University Medical School Department of Parasitology, Manisa, Turkey
No information available.
No information available
Received Date: 25.06.2004
Accepted Date: 28.07.2004
PDF
Cite
Share
Request

ABSTRACT

A 45 year-old female was admitted to Department of Infectious Diseases of Social Security Hospital, Tepecik, İzmir. She was found to have hepatosplenomegaly; pancytopenia and hypergammaglobulinemia during physical and laboratory examinations. Leishmania amastigotes were seen in the bone marrow smears and serological and bacteriological tests were all found to be positive. The patient was given diagnoses of visceral leishmaniasis and salmonellosis. A dosage regimen of Amphotericin B lipid complex (Abelcet®) infusion was given intermittently and this was found to be effective in the treatment of visceral leishmaniasis.

Keywords: Leishmaniasis, visceral, Abelcet, case report

References

2024 ©️ Galenos Publishing House